Roger D. Dansey holds the position of Chief Medical Officer for Seattle Genetics, Inc.

In the past he was Vice President-Oncology Clinical Research at Gilead Sciences, Inc. and SVP & Head-Therapeutic Area at Merck Research Laboratories.

He received a doctorate from the University of the Witwatersrand.